Search

"COVID-19" - search results

If you're not happy with the results, please do another search

WEBINAR | Creative Responses to COVID-19:  Automatic Vaccination Billing, Drive Up Antibody Infusions and EMR Interoperability

David Pape, VP, Technology, Palomar Health; Kurt Romeiser, Senior Clinical Informaticist, Tiger Institute Health Alliance; Prudence Myers, MHA, CPhT, Sr. Decision Support Analyst, University Physicians Revenue Integrity, Plan Administration, University of Missouri Health Care; and Dick Flanigan, MBA, FACHE, SVP,  Cerner. Healthcare organizations are finding creative ways to handle COVID-19 surges and vaccinate members of the community.  At the University...

WEBINAR | COVID-19: What Do We Really Know about Emergence, Treatments and Vaccines?

John McConnell, Editor-in-Chief, The Lancet Infectious Diseases. Despite an unprecedented scientific effort, uncertainties remain in our knowledge of COVID-19. Efforts to prevent and treat the COVID-19 pandemic have been further complicated by the spread of misinformation about the disease. This teleconference attempts to untangle myth from reality in what we [...]

COVID-19 Community Immunity for All Initiative at Atrium Health

Scott Rissmiller, MD, EVP & Chief Physician Executive, and Kinneil Coltman, DHA, SVP, Chief Community & Social Impact Officer, Atrium Health. Atrium Health’s “Community Immunity For All” collaborative has a united goal to ensure equity in access to COVID-19 vaccines, acknowledge the history of health injustice in communities of color, listen to and collaborate with partner organizations, and support...

UH4YOU: Building Resilience During COVID-19 and Beyond at University Hospitals

Francoise Adan, MD, ABIHM, Director of Connor Integrative Health Network, University Hospitals. Burnout and compassion fatigue are serious concerns for caregivers across the healthcare industry and we are seeing their effects now more than ever before. To respond to the additional professional and personal stressors, losses, and challenges caused by the COVID-19 pandemic, University Hospitals (UH) developed a resilience...

COVID-19 Seropositivity and Asymptomatic Rates in Healthcare Workers at Beaumont

Hans Keil, MBA, SVP & CIO, and Matthew Sims, MD, PhD, Director of Infectious Disease Research, Beaumont Health.  Beaumont Health conducted a major study of over 20,000 employees during the height of last spring’s COVID-19 surge, leveraging their IT and Lab teams, to understand the risk of exposure for frontline healthcare workers.  Determining infection rate can be difficult due...

Predictive Models, Bias, Health Equity, and COVID-19

Michael Pencina, PhD, Vice Dean for Data Science and IT & Professor of Biostatistics and Bioinformatics, Duke University School of Medicine. Modern health systems stand to derive substantial benefit from employing algorithm-based clinical decision support (ABCDS) tools. However, adoption has been slow and recent high profile failures have raised concerns about bias and inequity, lack of transparency and trust,...

COVID-19 Immunity Research at Mass General Brigham

Duane Wesemann, MD, PhD, Associate Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital. It is relatively well-known that the immune system produces antibodies in response to COVID-19 infection, but how long these antibody responses last continues to be unclear, and the heterogeneity of immune responses to COVID-19 makes it difficult to develop predictive models. Dr....

Leverage a Digital Practice to Advance Consumer Engagement amid COVID-19 and Beyond 

Tom Pacek, CIO, Inspira Health, and David Harse, VP and GM, Consumer Engagement, Cerner.  As the healthcare industry undergoes a shift in consumer behavior patterns, providers are challenged with finding new opportunities to meet consumer expectations in delivering quality care.  Rising healthcare costs, a desire for more transparent health data, and the influence of digital and mobile technology...

Study: Robust T-Cell Immunity Found in Those with Asymptomatic, Mild COVID-19

Marcus Buggert, PhD, Assistant Professor, Department of Medicine Huddinge, Karolinska Institute, Sweden.  Dr. Buggert is a viral immunologist that has focused his career on T cells in the context of HIV infection. During this teleconference, Dr. Buggert describes the most recent data on T cell immunity in COVID-19 patients. Additionally, he provides an update on the "knowns" and "unknowns"...

Addressing Inequity in COVID-19 Outcomes

Kenneth J. Fawcett Jr., MD, Vice President, Healthier Communities, Spectrum Health.  Dr. Fawcett asks and attempts to answer how we can create equitable outcomes among disadvantaged populations in the context of an active pandemic.  He describes strategies to reduce COVID-19 infections, explains how to proactively reach out to patients who are at greatest risk outside of a medical model,...